Flow cytometric immunophenotypic characterization of pediatric and adult minimally differentiated acute myeloid
P K Kotylo1, I S Seo, F O Smith
1Indiana University School of Medicine, Indianapolis, USA.
Abstract:
We reviewed the clinicopathologic and immunophenotypic profiles of 7 pediatric and 11 adult minimally differentiated acute myelogenous leukemias (AML-M0). We also compared and evaluated myeloperoxidase in leukemic blasts using standard cytochemical and polyclonal antibody immunohistochemical stains. No distinctive clinical findings were noted in either patient group; however, thrombocytopenia typically was more prominent in adults. Adult AML-M0 also was associated with an immature myeloid profile (CD34+, terminal deoxynucleotidyl transferase positive, CD13+, and CD33+), in contrast with pediatric AML-M0, which usually lacked terminal deoxynucleotidyl transferase or CD34 but expressed bright CD33 with weak or negative CD13. Coexpression of the T-cell-associated antigen CD7 was observed in both groups. Antibody immunohistochemical stains were more sensitive than cytochemical stains for detection of myeloperoxidase activity and a useful adjunct for establishing a diagnosis of myeloid leukemia in paraffin-embedded marrow tissues.
Insights
Pediatric and adult minimally differentiated acute myelogenous leukemia (AML-M0) show distinct immunophenotypic profiles. Antibody immunohistochemical stains are more sensitive for detecting myeloperoxidase activity in AML-M0 diagnosis.
Area of Science:
- Hematology
- Oncology
- Immunophenotyping
Background:
- Minimally differentiated acute myelogenous leukemia (AML-M0) is a rare subtype.
- Understanding immunophenotypic differences between pediatric and adult AML-M0 is crucial for diagnosis and treatment.
- Myeloperoxidase (MPO) expression is a key marker in myeloid leukemia diagnosis.
Purpose of the Study:
- To compare clinicopathologic and immunophenotypic profiles of pediatric and adult AML-M0.
- To evaluate myeloperoxidase detection methods in leukemic blasts.
- To assess the utility of antibody immunohistochemical stains versus cytochemical stains for MPO activity.
Main Methods:
- Review of clinicopathologic and immunophenotypic data from 7 pediatric and 11 adult AML-M0 cases.
- Comparison of myeloperoxidase detection using standard cytochemical stains and polyclonal antibody immunohistochemical stains.
- Analysis of cell surface marker expression including CD34, terminal deoxynucleotidyl transferase (TdT), CD13, CD33, and CD7.
Main Results:
- No significant clinical differences were observed between pediatric and adult AML-M0, except for more prominent thrombocytopenia in adults.
- Adult AML-M0 exhibited an immature myeloid profile (CD34+, TdT+, CD13+, CD33+).
- Pediatric AML-M0 typically lacked TdT or CD34 but showed bright CD33 and weak/negative CD13. CD7 coexpression was noted in both groups.
- Antibody immunohistochemical stains demonstrated higher sensitivity for MPO detection compared to cytochemical stains.
Conclusions:
- Distinct immunophenotypic profiles differentiate pediatric and adult AML-M0.
- Antibody immunohistochemical staining is a more sensitive method for detecting MPO activity.
- Immunohistochemical stains are valuable adjuncts for diagnosing myeloid leukemia in bone marrow tissues.
